Differential splicing of COL6A3, and in particular of exon 4, has previously been associated with pancreatic cancer [44] and colon cancer [45], though in these studies it was inclusion as opposed to exclusion of exon 4 that associated with the disease phenotype. The gene discussed is COL6A3; the disease is pancreatic neoplasm.